Screener
Merit Medical Systems MMSI Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| ASSETS | March 31, 2026 | December 31, 2025 |
|---|---|---|
| (unaudited) | ||
| Current assets: | ||
| Cash and cash equivalents | $488,080 | $446,404 |
| Trade receivables — net of allowance for credit losses — 2026 — $10,348 and 2025 — $10,136 | 206,446 | 203,710 |
| Other receivables | 18,717 | 17,773 |
| Inventories | 352,386 | 333,705 |
| Prepaid expenses and other current assets | 29,274 | 31,493 |
| Prepaid income taxes | 5,033 | 4,941 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's cash & equivalents?
- Merit Medical Systems (MMSI) reported cash & equivalents of $488.08M in Q1 2026.
- How has Merit Medical Systems's cash & equivalents changed year-over-year?
- Merit Medical Systems's cash & equivalents increased by 23.4% year-over-year, from $395.53M to $488.08M.
- What is the long-term trend for Merit Medical Systems's cash & equivalents?
- Over 5 years (2020 to 2025), Merit Medical Systems's cash & equivalents has grown at a 51.0% compound annual growth rate (CAGR), from $56.92M to $446.4M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Merit Medical Systems's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude